Another significant development in the influenza vaccine market is the use of cell-based technology for vaccine production. Traditional egg-based vaccine production can be time-consuming and less effective, as the vaccine can be affected by mutations in the virus during the production process. Cell-based vaccine production allows for faster and more efficient production of the vaccine, which could lead to improved vaccine efficacy.
In conclusion, the U.S. influenza vaccine market is a vital part of the healthcare industry. The demand for the vaccine is expected to grow in the coming years, driven by government initiatives, increasing prevalence of the flu, and growing awareness about the benefits of vaccination.
Read More:
https://knackersblogger.blogspot.com/2023/03/us-influenza-vaccines-market-size-share.html
